You can buy or sell IMV and other stocks, options, ETFs, and crypto commission-free!
IMV Inc. Common Shares, also called IMV, is a clinical-stage biopharmaceutical company, which engages in the development of cancer immunotherapies and infectious disease vaccines. Read More The firm's patented platform, DepoVax, provides controlled and prolonged exposure of antigens and adjuvant to the immune system. The company was founded by Warwick Kimmins and Brian Lowe on March 28, 2000 and is headquartered in Halifax, Canada.
Halifax, Nova Scotia
52 Week High
52 Week Low
IMV Inc. to Present at Two Upcoming Investor Conferences
IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical stage immuno-oncology company, today announced that IMV Chief Executive Officer Frederic Ors will present at the Spring Investor Summit and the HC Wainwright Global Life Sciences Conference during April 2019. Details on each conference and presentation are as follows: • Venue: Spring Investor Summit, being held April 1-2, 2019 • Date of Presentation: Monday, April 1 • Time: 8:30 a.m. ET • Location: JW Marriott Hotel, Essex House, New York City • Venue: HC Wainw...
Seeking AlphaMar 22
IMV INC (IMMVD) CEO Fred Ors on Q4 2018 Results - Earnings Call Transcript
IMV INC (OTCQX:IMMVD) Q4 2018 Earnings Conference Call March 22, 2019 8:00 AM ET Company Participants Pierre Labbé - CFO Fred Ors - CEO Stephan Fiset - VP, Clinical Research Conference Call Participants David Novak - Raymond James Andre Uddin - Mackie Research Capital Endri Leno - National Bank Doug Loe - Echelon Wealth Partners Operator Good day, ladies and gentlemen, and welcome to the IMV 2018 Earnings Call. At this time, all lines are in a listen-only mode. Later we will conduct a question-an...